Impairment of PTEN function from PTEN oxidation has been reported previously (29–32), but the precise mechanism how variants and mutations in mitochondrial tumor suppressors such as SDH lead to carcinogenesis phenotypes in patients is not clear yet. This evidence concerns the gene SDHB and neoplasm.